Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedJul 19, 2025
DataAggregated Company Financials
Companies21
  • 7D-4.3%
  • 3M-0.8%
  • 1Y-50.1%
  • YTD-31.9%

Over the last 7 days, the Healthcare industry has dropped 4.3%, driven by a pullback from Novo Nordisk of 5.5%. However, the industry is down 50% over the past year. As for the next few years, earnings are expected to grow by 12% per annum.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 19 Jul 2025DKK 2.3tDKK 423.3bDKK 124.5b29.9x18.4x5.4x
Mon, 16 Jun 2025DKK 2.8tDKK 423.4bDKK 124.6b31.4x22.3x6.5x
Wed, 14 May 2025DKK 2.4tDKK 423.4bDKK 124.9b23x19.1x5.6x
Fri, 11 Apr 2025DKK 2.3tDKK 409.3bDKK 121.3b21.2x18.6x5.5x
Sun, 09 Mar 2025DKK 3.2tDKK 409.5bDKK 121.3b27x26.1x7.7x
Tue, 04 Feb 2025DKK 3.3tDKK 387.8bDKK 111.4b28.2x29.2x8.4x
Thu, 02 Jan 2025DKK 3.3tDKK 387.4bDKK 111.3b29.9x29.6x8.5x
Sat, 30 Nov 2024DKK 3.9tDKK 387.3bDKK 111.3b31.2x35.2x10.1x
Mon, 28 Oct 2024DKK 4.1tDKK 372.2bDKK 107.2b34x37.9x10.9x
Wed, 25 Sep 2024DKK 4.3tDKK 371.9bDKK 107.1b37x40.1x11.5x
Fri, 23 Aug 2024DKK 4.7tDKK 371.9bDKK 107.1b36.3x43.9x12.6x
Sun, 21 Jul 2024DKK 4.6tDKK 355.3bDKK 106.2b35.6x43.3x12.9x
Tue, 18 Jun 2024DKK 4.9tDKK 355.3bDKK 106.2b35.7x46.2x13.8x
Thu, 16 May 2024DKK 4.7tDKK 355.4bDKK 106.6b35.3x43.8x13.1x
Sat, 13 Apr 2024DKK 4.5tDKK 341.3bDKK 99.7b33.5x45.1x13.2x
Mon, 11 Mar 2024DKK 4.7tDKK 341.2bDKK 99.6b39.6x46.7x13.6x
Wed, 07 Feb 2024DKK 4.2tDKK 338.6bDKK 98.5b34.8x42.3x12.3x
Fri, 05 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b33.1x41.9x11.8x
Sun, 03 Dec 2023DKK 3.6tDKK 320.5bDKK 90.0b32.8x40.3x11.3x
Tue, 31 Oct 2023DKK 3.5tDKK 305.6bDKK 82.3b26.5x42.5x11.4x
Thu, 28 Sep 2023DKK 3.4tDKK 305.5bDKK 82.2b32.9x41.5x11.2x
Sat, 26 Aug 2023DKK 3.4tDKK 305.2bDKK 82.1b35.4x41.2x11.1x
Mon, 24 Jul 2023DKK 3.0tDKK 287.0bDKK 75.4b40.6x40.1x10.6x
Wed, 21 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b40x39.7x10.4x
Fri, 19 May 2023DKK 3.2tDKK 285.6bDKK 74.6b41.4x42.4x11.1x
Sun, 16 Apr 2023DKK 3.2tDKK 272.6bDKK 68.5b43x46x11.6x
Tue, 14 Mar 2023DKK 2.7tDKK 292.6bDKK 69.2b37.1x39.7x9.4x
Thu, 09 Feb 2023DKK 2.8tDKK 287.5bDKK 68.7b38x40.1x9.6x
Sat, 07 Jan 2023DKK 2.8tDKK 276.1bDKK 66.3b38.3x41.5x10x
Mon, 05 Dec 2022DKK 2.6tDKK 276.1bDKK 66.3b38.4x39.6x9.5x
Wed, 02 Nov 2022DKK 2.4tDKK 261.3bDKK 62.4b37.3x38.2x9.1x
Fri, 30 Sep 2022DKK 2.2tDKK 261.3bDKK 62.4b33.6x35.5x8.5x
Sun, 28 Aug 2022DKK 2.4tDKK 260.2bDKK 62.5b36.7x38.9x9.3x
Tue, 26 Jul 2022DKK 2.5tDKK 247.8bDKK 59.9b37.7x41.4x10x
Price to Earnings Ratio

41.4x


Total Market Cap: DKK 2.5tTotal Earnings: DKK 59.9bTotal Revenue: DKK 247.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 37.6x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 18.4x which is lower than its 3-year average PE of 37.6x.
  • The 3-year average PS ratio of 10.2x is higher than the industry's current PS ratio of 5.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 28% per year over the last three years.
  • Revenues for these companies have grown 20% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market-1.99%
Healthcare-4.29%
Biotech2.09%
Healthtech1.82%
Medical Equipment1.63%
Healthcare Services1.06%
Life Sciences-2.43%
Pharma-5.39%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 102x.
    • Analysts are expecting annual earnings growth of 13.5%, which is lower than the prior year's growth of 17.6% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 60% over the next 5 years.
  • This is better than its past earnings decline of 48% per year.
  • In contrast, the Biotech industry is expected to see its earnings growth to stay flat over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.42k3.0%
+DKK 2.6b		-24.1%PE11.9x
DEMANT DemantDKK 272.003.2%
+DKK 1.8b		9.1%PE20x
COLO B ColoplastDKK 606.201.0%
+DKK 1.4b		-29.3%PE30x
AMBU B AmbuDKK 98.802.6%
+DKK 679.3m		-26.2%PE71.1x
BAVA Bavarian NordicDKK 184.602.2%
+DKK 303.6m		-0.2%PE10.9x

Latest News

ALK B
DKK 194.20
ALK-Abelló
7D
-0.2%
1Y
27.4%
AMBU B
DKK 98.80
Ambu
7D
2.6%
1Y
-26.2%

Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Jul 12
Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?
EMBLA
DKK 32.40
Embla Medical hf
7D
-0.3%
1Y
9.5%

Is Embla Medical hf (CPH:EMBLA) Using Too Much Debt?

Jul 10
Is Embla Medical hf (CPH:EMBLA) Using Too Much Debt?
CHEMM
DKK 525.00
ChemoMetec
7D
-2.4%
1Y
43.8%

ChemoMetec A/S' (CPH:CHEMM) Popularity With Investors Is Under Threat From Overpricing

Jul 07
ChemoMetec A/S' (CPH:CHEMM) Popularity With Investors Is Under Threat From Overpricing
GMAB
DKK 1,419.50
Genmab
7D
3.0%
1Y
-24.1%
BIOPOR
DKK 1.37
BioPorto
7D
-2.1%
1Y
-37.9%
GUBRA
DKK 404.60
Gubra
7D
-2.5%
1Y
-31.4%

Gubra A/S' (CPH:GUBRA) 35% Jump Shows Its Popularity With Investors

Jun 28
Gubra A/S' (CPH:GUBRA) 35% Jump Shows Its Popularity With Investors
NOVO B
DKK 414.60
Novo Nordisk
7D
-5.5%
1Y
-54.2%
ZEAL
DKK 363.10
Zealand Pharma
7D
-0.9%
1Y
-58.0%
HLUN B
DKK 33.86
H. Lundbeck
7D
-2.8%
1Y
-15.1%
BAVA
DKK 184.60
Bavarian Nordic
7D
2.2%
1Y
-0.2%

Earnings Working Against Bavarian Nordic A/S' (CPH:BAVA) Share Price

Jun 13
Earnings Working Against Bavarian Nordic A/S' (CPH:BAVA) Share Price
DEMANT
DKK 272.00
Demant
7D
3.2%
1Y
9.1%
COLO B
DKK 606.20
Coloplast
7D
1.0%
1Y
-29.3%

Investors Still Waiting For A Pull Back In Coloplast A/S (CPH:COLO B)

May 25
Investors Still Waiting For A Pull Back In Coloplast A/S (CPH:COLO B)
STENO
DKK 0.68
Stenocare
7D
7.0%
1Y
-82.2%
NNIT
DKK 69.40
NNIT
7D
1.8%
1Y
-35.5%

These 4 Measures Indicate That NNIT (CPH:NNIT) Is Using Debt Reasonably Well

May 16
These 4 Measures Indicate That NNIT (CPH:NNIT) Is Using Debt Reasonably Well
STRAP
DKK 1,195.00
Strategic Partners
7D
14.9%
1Y
39.0%